Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Marksans Pharm Marksans Pharma Ltd. | BSE 179.75 -0.40 (-0.22%) | NSE 179.87 -0.42 (-0.23%) | Trade | Add

BSE Live

Jan 01, 16:01

179.75 -0.40 (-0.22%)

Volume

AVERAGE VOLUME

5-Day

30,574

10-Day

32,314

30-Day

42,037

17,329

Prev. Close

180.15
Open Price

180.20

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 01, 15:58

179.87 -0.42 (-0.23%)

Volume

AVERAGE VOLUME

5-Day

449,399

10-Day

482,436

30-Day

660,873

318,058

Prev. Close

180.29
Open Price

181.80

Bid Price (Qty.)
179.87 (165)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Marksans Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	428.54	411.42	286.04	207.52	348.15
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	428.54	411.42	286.04	207.52	348.15
Total Operating Revenues	433.42	424.16	294.66	215.84	358.13
Other Income	0.17	7.93	7.43	6.95	8.69
Total Revenue	433.59	432.09	302.09	222.79	366.82
EXPENSES
Cost Of Materials Consumed	209.20	208.14	154.74	100.88	156.72
Purchase Of Stock-In Trade	39.46	30.91	18.33	10.82	17.30
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-5.63	-2.71	-3.72	0.67	4.16
Employee Benefit Expenses	48.51	46.33	45.86	39.77	26.13
Finance Costs	7.29	6.56	7.67	4.49	6.20
Depreciation And Amortisation Expenses	11.64	8.69	12.25	15.00	14.75
Other Expenses	70.39	78.16	50.31	39.21	49.92
Total Expenses	380.86	376.08	285.44	210.84	275.19
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	52.73	56.01	16.65	11.95	91.63
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	52.73	56.01	16.65	11.95	91.63
Tax Expenses-Continued Operations
Current Tax	11.60	12.11	3.62	2.84	24.98
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	3.68	1.00	0.60	0.70	-0.19
Tax For Earlier Years	-0.45	-0.72	0.00	-3.14	-4.64
Total Tax Expenses	14.82	12.39	4.23	0.40	20.14
Profit/Loss After Tax And Before ExtraOrdinary Items	37.90	43.62	12.43	11.55	71.49
Profit/Loss From Continuing Operations	37.90	43.62	12.43	11.55	71.49
Profit/Loss For The Period	37.90	43.62	12.43	11.55	71.49
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	0.93	1.07	0.30	0.28	1.75
Diluted EPS (Rs.)	0.93	1.07	0.30	0.28	1.75
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS
Imported Raw Materials	55.24	36.54	38.99	28.20	66.95
Indigenous Raw Materials	153.96	171.60	115.75	72.68	89.77
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares	0.00	0.00	0.00	0.00	0.00
Indigenous Stores And Spares	0.00	0.00	0.00	0.00	0.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	2.47	2.05	2.46	5.91	5.79
Tax On Dividend	0.00	0.00	0.00	0.00	1.18
Equity Dividend Rate (%)	10.00	5.00	5.00	5.00	12.00